Axsome Therapeutics Inc Stock
Price
Target price
€126.25
€126.25
-0.430%
-0.55
-0.430%
€75.50
12.12.25 / Tradegate
WKN: A2AA7B / Name: Axsome / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Axsome Therapeutics Inc is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for Axsome
sharewise wants to provide you with the best news and tools for Axsome, so we directly link to the best financial data sources.
Financials
News
2 Under-the-Radar Stocks to Buy Heading Into 2026
Axsome Therapeutics (NASDAQ: AXSM) and Exelixis (NASDAQ: EXEL) are hardly the best-known players in the large biotech industry. Thankfully, they don't need to be so to have excellent prospects. Both
Axsome (AXSM) Q2 Revenue Soars 72%
Axsome Therapeutics (NASDAQ:AXSM), a biopharmaceutical company focused on central nervous system (CNS) disorders, released its earnings on August 4, 2025. The company reported GAAP revenue of $150.0